Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19 (QG-PASC)

POCHIWU

Status: Enrolling

Conditions: PASC Post Acute Sequelae of COVID 19

Treatments: Behavioral: QI-GONG and control

Study type: Interventional

Funder types: Other

Identifiers

NCT06879925

NTUNHS

CTH-113-3-5-030

Details and patient eligibility

About

The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC).

Study Objectives:

To assess whether Qi-Gong improves physiological function in individuals with PASC.

To evaluate whether Qi-Gong enhances quality of life in individuals with PASC.

Study Design:

If a comparison group is included, researchers will compare Qi-Gong with standard care to assess its effectiveness.

Participant Involvement:

Practice Qi-Gong three times per week for three months. Record physiological data monthly.

Enrollment: 80 estimated patients

Sex: All

Ages: 20 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• PASC
• above 20 y/o

Exclusion criteria

• Those who cannot cooperate
• Severe schizophrenia

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

80 participants in 2 patient groups

Qi-Gong Group

Experimental group

Description:

Experimental Group :Qi-Gong(yijinjing)

Treatment:

Behavioral: QI-GONG and control

routine care Group

No Intervention group

Description:

Control Group:routine care